Epidemiology and aetiology of c4–6 disease

Phlebology

Volumn 25, Issue , 2010, Pages 2-8

  Bradbury, Andrew W ^a,b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

CEAP classification; Chronic venous insufficiency; Varicose ulcer; Varicose veins

Indexed keywords

FIBROBLAST; GENETICS; HUMAN; HYPERTENSION; INCIDENCE; INFLAMMATION; MICROCIRCULATION; PATHOLOGY; REVIEW; SKELETAL MUSCLE; THROMBOPHILIA; VARICOSIS; VASCULAR DISEASE; VEIN INSUFFICIENCY;

FIBROBLASTS; HUMANS; HYPERTENSION; INCIDENCE; INFLAMMATION; MICROCIRCULATION; MUSCLE, SKELETAL; THROMBOPHILIA; VARICOSE VEINS; VASCULAR DISEASES; VENOUS INSUFFICIENCY;

EID: 79952117727     PISSN: 02683555     EISSN: 14333031     Source Type: Journal    
DOI: 10.1258/phleb.2010.010s01     Document Type: Article

References (72)

1. Gohel MS, Barwell JR, Earnshaw JJ, et al. Randomized clinical trial of compression plus surgery versus compression alone in chronic venous ulceration (ESCHAR study) – haemodynamic and anatomical changes. Br J Surg 2005;92:291–7
2. Gohel MS, Barwell JR, Taylor M, et al. Long term results of compression therapy alone versus compression plus surgery in chronic venous ulceration (ESCHAR): ran-domised controlled trial. BMJ 2007;335:83
3. Gohel MS, Davies AH. Pharmacological agents in the treatment of venous disease: an update of the available evidence. Curr Vasc Pharmacol 2009;7:303–8
4. Campbell WB, Thomson H, MacIntyre JB, Coward C, Michaels JA. Venous ulcer services in the United Kingdom. Eur J Vasc Endovasc Surg 2005;30:437–40
5. Ragnarson Tennvall G, Hjelmgren J. Annual costs of treatment for venous leg ulcers in Sweden and the United Kingdom. Wound Repair Regen 2005;13:13–18
6. Howard DP, Howard A, Kothari A, Wales L, Guest M, Davies AH. The role of superficial venous surgery in the management of venous ulcers: a systematic review. Eur J Vasc Endovasc Surg 2008;36: 458–65
7. Moor AN, Vachon DJ, Gould LJ. Proteolytic activity in wound fluids and tissues derived from chronic venous leg ulcers. Wound Repair Regen 2009;17:832–9
8. O’Meara S, Cullum NA, Nelson EA. Compression for venous leg ulcers. Cochrane Database Syst Rev 2009; CD000265
9. Evans CJ, Allan PL, Lee AJ, Bradbury AW, Ruckley CV, Fowkes FG. Prevalence of venous reflux in the general population on duplex scanning: the Edinburgh vein study. J Vasc Surg 1998;28:767–76
10. Ruckley CV, Evans CJ, Allan PL, Lee AJ, Fowkes FG. Chronic venous insufficiency: clinical and duplex corre-lations. The Edinburgh Vein Study of venous disorders in the general population. J Vasc Surg 2002;36:520–5
11. Vowden KR, Vowden P. The prevalence, management and outcome for patients with lower limb ulceration identified in a wound care survey within one English health care district. J Tissue Viability 2009;18:13–19
12. Abbade LP, Lastoria S, de Almeida Rollo H, Stolf HO. A sociodemographic, clinical study of patients with venous ulcer in Brazil. Int J Dermatol 2005;44:989–92
13. Abbade LP, Lastoria S. Venous ulcer: epidemiology, phy-siopathology, diagnosis and treatment. Int J Dermatol 2005;44:449–56
14. Shai A, Halevy S. Direct triggers for ulceration in patients with venous insufficiency. Int J Dermatol 2005;44:1006–9
15. Labropoulos N, Patel PJ, Tiongson JE, Pryor L, Leon LR Jr Tassiopoulos AK. Patterns of venous reflux and obstruction in patients with skin damage due to chronic venous disease. Vasc Endovasc Surg 2007;41: 33–40
16. Simka M. Calf muscle pump impairment and delayed healing of venous leg ulcers: air plethysmographic find-ings. J Dermatol 2007;34:537–44
17. Panny M, Ammer K, Kundi M, Katzenschlager R, Hirschl M. Severity of chronic venous disorders and its relationship to the calf muscle pump. Vasa 2009;38:171–6
18. Kulkarni SR, Barwell JR, Gohel MS, Bulbulia RA, Whyman MR, Poskitt KR. Residual venous reflux after superficial venous surgery does not predict ulcer recur-rence. Eur J Vasc Endovasc Surg 2007;34:107–11
19. Moloney MC, Lyons GM, Egan M, et al. Does size matter? The impact of calf muscle volume on venous return in patients with venous leg ulcers. Phlebology 2007;22:65–9
20. Milic DJ, Zivic SS, Bogdanovic DC, Karanovic ND, Golu-bovic ZV. Risk factors related to the failure of venous leg ulcers to heal with compression treatment. J Vasc Surg 2009;49:1242–7
21. Pascarella L, Schonbein GW, Bergan JJ. Microcirculation and venous ulcers: a review. Ann Vasc Surg 2005; 19:921–7
22. Nicolaides AN. Chronic venous disease and the leukocyte-endothelium interaction: from symptoms to ulceration. Angiology 2005;56 (Suppl. 1):S11–19
23. Mlacak B, Blinc A, Gale N, Ivka B. Microcirculation dis-turbances in patients with venous ulcer before and after healing as assessed by laser Doppler flux-metry. Arch Med Res 2005;36:480–4
24. Bergan J. Molecular mechanisms in chronic venous insufficiency. Ann Vasc Surg 2007;21: 260–6
25. Maksimovic Z, Maksimovic M. Local metabolic, patho-physiological and histological changes in venous ulcers. Phlebology 2007;22:110–15
26. Kobrin KL, Thompson PJ, van de Scheur M, Kwak TH, Kim S, Falanga V. Evaluation of dermal pericapillary fibrin cuffs in venous ulceration using confocal microscopy. Wound Repair Regen 2008;16:503–6
27. Raffetto JD. Dermal pathology, cellular biology, and inflammation in chronic venous disease. Thromb Res 2009;123(Suppl. 4):S66–71
28. Ambrosch A, Lobmann R, Pott A, Preissler J. Interleukin-6 concentrations in wound fluids rather than serological markers are useful in assessing bacterial triggers of ulcer inflammation. Int Wound J 2008;5: 99–106
29. Charles CA, Romanelli P, Martinez ZB, Ma F, Roberts B, Kirsner RS. Tumour necrosis factor-alfa in nonhealing venous leg ulcers. J Am Acad Dermatol 2009;60:951–5
30. Subramaniam K, Pech CM, Stacey MC, Wallace HJ. Induction of MMP-1, MMP-3 and TIMP-1 in normal dermal fibroblasts by chronic venous leg ulcer wound fluid. Int Wound J 2008;5:79–86
31. Beidler SK, Douillet CD, Berndt DF, Keagy BA, Rich PB, Marston WA. Multiplexed analysis of matrix metallopro-teinases in leg ulcer tissue of patients with chronic venous insufficiency before and after compression therapy. Wound Repair Regen 2008;16:642–8
32. Beidler SK, Douillet CD, Berndt DF, Keagy BA, Rich PB, Marston WA. Inflammatory cytokine levels in chronic venous insufficiency ulcer tissue before and after compression therapy. J Vasc Surg 2009;49:1013–20
33. Guarnera G, DE Rosa A, Camerini R. Thymosin beta-4 and venous ulcers: clinical remarks on a European prospective, randomized study on safety, tolerability, and enhancement on healing. Ann N YAcad Sci 2007;1112: 407–12
34. Margolis DJ, Morris LM, Papadopoulos M, et al. Phase I study of H5.020CMV.PDGF-beta to treat venous leg ulcer disease. Mol Ther 2009;17:1822–9
35. Cianfarani F, Tommasi R, Failla CM, et al. Granulocyte/ macrophage colony-stimulating factor treatment of human chronic ulcers promotes angiogenesis associated with de novo vascular endothelial growth factor tran-scription in the ulcer bed. Br J Dermatol 2006;154:34–41
36. Gohel MS, Windhaber RA, Tarlton JF, Whyman MR, Poskitt KR. The relationship between cytokine concentrations and wound healing in chronic venous ulcera-tion. J Vasc Surg 2008;48:1272–7
37. Harding KG, Moore K, Phillips TJ. Wound chronicity and fibroblast senescence–implications for treatment. Int Wound J 2005;2:364–8
38. Pappas PJ, Lal BK, Ohara N, Saito S, Zapiach L, Duran WN. Regulation of matrix contraction in chronic venous disease. Eur J Vasc Endovasc Surg 2009;38:518–29
39. Raffetto JD, Gram CH, Overman KC, Menzoian JO. Mitogen-activated protein kinase p38 pathway in venous ulcer fibroblasts. Vasc Endovasc Surg 2008;42: 367–74
40. Gemmati D, Federici F, Catozzi L, et al. DNA-array of gene variants in venous leg ulcers: detection of prognos-tic indicators. J Vasc Surg 2009;50:1444–51
41. Degiorgio-Miller AM, Treharne LJ, McAnulty RJ, Coler-idge Smith PD, Laurent GJ, Herrick SE. Procollagen type I gene expression and cell proliferation are increased in lipodermatosclerosis. Br J Dermatol 2005;152:242–9
42. Stojadinovic O, Pastar I, Vukelic S, et al. Deregulation of keratinocyte differentiation and activation: a hallmark of venous ulcers. J Cell Mol Med 2008;12(6B):2675–90
43. Heising S, Giebel J, Ostrowitzki AL, et al. Evaluation of apoptotic cells and immunohistochemical detection of FAS, FAS-L, Bcl-2, Bax, p53 and c-Myc in the skin of patients with chronic venous leg ulcers. Int J Mol Med 2008;22:497–505
44. Nagy N, Nemeth IB, Szabad G, et al. The altered expression of syndecan 4 in the uninvolved skin of venous leg ulcer patients may predispose to venous leg ulcer. Wound Repair Regen 2008;16:495–502
45. Darvall KA, Sam RC, Adam DJ, Silverman SH, Fegan CD, Bradbury AW. Higher prevalence of thrombophilia in patients with varicose veins and venous ulcers than controls. J Vasc Surg 2009;49:1235–41
46. Durmazlar SP, Akgul A, Eskioglu F. Hyperhomocystei-nemia in patients with stasis dermatitis and ulcer: a novel finding with important therapeutic implications. J Dermatol Treat 2009;20:336–9
47. Lee AJ, Lowe GD, Rumley A, Ruckley CV, Fowkes FG. Haemostatic factors and risk of varicose veins and chronic venous insufficiency: Edinburgh Vein Study. Blood Coagul Fibrinolysis 2000;11:775–81
48. Schwartzfarb EM, Romanelli P. Hyperhomocysteinemia and lower extremity wounds. Int J Low Extrem Wounds 2008;7:126–36
49. Legendre C, Debure C, Meaume S, Lok C, Golmard JL, Senet P. Impact of protein deficiency on venous ulcer healing. J Vasc Surg 2008;48:688–93
50. Szewczyk MT, Jawien A, Kedziora-Kornatowska K, et al. The nutritional status of older adults with and without venous ulcers: a comparative, descriptive study. Ostomy Wound Manage 2008;54:34–6
51. Tobon J, Whitney JD, Jarrett M. Nutritional status and wound severity of overweight and obese patients with venous leg ulcers: a pilot study. J Vasc Nurs 2008;26: 43–52
52. O’Meara S, Al-Kurdi D, Ovington LG. Antibiotics and antiseptics for venous leg ulcers. Cochrane Database Syst Rev 2008;pCD003557
53. Bjarnsholt T, Kirketerp-Moller K, Jensen PO, et al. Why chronic wounds will not heal: a novel hypothesis. Wound Repair Regen 2008;16:2–10
54. Fazli M, Bjarnsholt T, Kirketerp-Moller K, et al. Nonran-dom distribution of Pseudomonas aeruginosa and Staphy-lococcus aureus in chronic wounds. J Clin Microbiol 2009;47:4084–9
55. Rhoads DD, Wolcott RD, Kuskowski MA, Wolcott BM, Ward LS, Sulakvelidze A. Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial. J Wound Care 2009;18:237–8
56. Tan J, Smith A, Abisi S, Eastham D, Burnand KG. Tissue and urinary haemosiderin in chronic leg ulcers. Eur J Vasc Endovasc Surg 2007;34:355–60
57. Ashworth JJ, Smyth JV, Pendleton N, et al. Polymorph-isms spanning the 0N exon and promoter of the estrogen receptor-beta (ERbeta) gene ESR2 are associated with venous ulceration. Clin Genet 2008;73:55–61
58. Charles CA, Tomic-Canic M, Vincek V, et al. A gene sig-nature of nonhealing venous ulcers: potential diagnostic markers. J Am Acad Dermatol 2008;59:758–71
59. Herouy Y, Kreis S, Mueller T, et al. Inhibition of angio-genesis in lipodermatosclerosis: implication for venous ulcer formation. Int J Mol Med 2009;24:645–51
60. Fiebig A, Krusche P, Wolf A, et al. Heritability of chronic venous disease. Hum Genet 2010;127:669–74
61. Briggs M, Nelson EA. Topical agents or dressings for pain in venous leg ulcers. Cochrane Database Syst Rev 2010;4:pCD001177
62. Zamboni P, Gemmati D. Clinical implications of gene polymorphisms in venous leg ulcer: a model in tissue injury and reparative process. Thromb Haemost 2007; 98:131–7
63. Tawfick W, Sultan S. Does topical wound oxygen (TWO2) offer an improved outcome over conventional compression dressings (CCD) in the management of refractory venous ulcers (RVU)? A parallel observational comparative study. Eur J Vasc Endovasc Surg 2009;38: 125–32
64. Guarnera G, DeRosa A, Camerini R. 8 European sites. The effect of thymosin treatment of venous ulcers. Ann N Y Acad Sci 2010;1194:207–12
65. Karatepe O, Unal O, Ugurlucan M, et al. The impact of valvular oxidative stress on the development of venous stasis ulcer valvular oxidative stress and venous ulcers. Angiology 2010;61:283–8
66. Angelova-Fischer I, Wuthe D, Zillikens D, Kahle B. Non-invasive bioengineering assessment of the skin barrier function in patients with chronic venous insufficiency. Br J Dermatol 2010;162:1071–5
67. Choh CT, Wall ML, Brown MD, Nicolson AM, Simms MH. Use of durometry in assessment of venous disease. Phlebology 2010;25:94–9
68. Pastar I, Stojadinovic O, Krzyzanowska A, et al. Attenu-ation of the transforming growth factor beta-signaling pathway in chronic venous ulcers. Mol Med 2010;16: 92–101
69. Peral MC, Rachid MM, Gobbato NM, Huaman Martinez MA, Valdez JC. Interleukin-8 production by polymor-phonuclear leukocytes from patients with chronic infected leg ulcers treated with Lactobacillus plantarum. Clin Microbiol Infect 2010;16:281–6
70. Moffatt CJ, Franks PJ, Doherty DC, Smithdale R, Steptoe A. Psychological factors in leg ulceration: a case-control study. Br J Dermatol 2009;161:750–6
71. Moffatt CJ, Doherty DC, Smithdale R, Franks PJ. Clinical predictors of leg ulcer healing. Br J Dermatol 2010;162: 51–8
72. Shiman MI, Pieper B, Templin TN, Birk TJ, Patel AR, Kirsner RS. Venous ulcers: a reappraisal analyzing the effects of neuropathy, muscle involvement, and range of motion upon gait and calf muscle function. Wound Repair Regen 2009;17:147–52